Suppr超能文献

直接经皮冠状动脉介入治疗对ST段抬高型心肌梗死患者的影响:一项综合分析。

Impact of primary percutaneous coronary intervention on ST-segment elevation myocardial infarction patients: A comprehensive analysis.

作者信息

Saeed Eza Nawzad, Faeq Abdulsatar Kamil

机构信息

Department of Medicine, Hawler Medical University, Erbil 44001, Kurdistan, Iraq.

出版信息

World J Exp Med. 2024 Mar 20;14(1):88541. doi: 10.5493/wjem.v14.i1.88541.

Abstract

BACKGROUND

Myocardial infarction, particularly ST-segment elevation myocardial infarction (STEMI), is a key global mortality cause. Our study investigated predictors of mortality in 96 STEMI patients undergoing primary percutaneous coronary intervention at Erbil Cardiac Center. Multiple factors were identified influencing in-hospital mortality. Significantly, time from symptom onset to hospital arrival emerged as a decisive factor. Consequently, our study hypothesis is: "Reducing time from symptom onset to hospital arrival significantly improves STEMI prognosis."

AIM

To determine the key factors influencing mortality rates in STEMI patients.

METHODS

We studied 96 consecutive STEMI patients undergoing primary percutaneous coronary intervention (PPCI) at the Erbil Cardiac Center. Their clinical histories were compiled, and coronary evaluations were performed angiography on admission. Data included comorbid conditions, onset of cardiogenic shock, complications during PPCI, and more. Post-discharge, one-month follow-up assessments were completed. Statistical significance was set at < 0.05.

RESULTS

Our results unearthed several significant findings. The in-hospital and 30-d mortality rates among the 96 STEMI patients were 11.2% and 2.3% respectively. On the investigation of independent predictors of in-hospital mortality, we identified atypical presentation, onset of cardiogenic shock, presence of chronic kidney disease, Thrombolysis In Myocardial Infarction grades 0/1/2, triple vessel disease, ventricular tachycardia/ventricular fibrillation, coronary dissection, and the no-reflow phenomenon. Specifically, the recorded average time from symptom onset to hospital arrival amongst patients who did not survive was significantly longer (6.92 ± 3.86 h) compared to those who survived (3.61 ± 1.67 h), < 0.001. These findings underscore the critical role of timely intervention in improving the survival outcomes of STEMI patients.

CONCLUSION

Our results affirm that early hospital arrival after symptom onset significantly improves survival rates in STEMI patients, highlighting the critical need for prompt intervention.

摘要

背景

心肌梗死,尤其是ST段抬高型心肌梗死(STEMI),是全球主要的死亡原因。我们的研究调查了埃尔比勒心脏中心96例接受直接经皮冠状动脉介入治疗的STEMI患者的死亡预测因素。确定了多个影响住院死亡率的因素。值得注意的是,从症状发作到入院的时间成为一个决定性因素。因此,我们的研究假设是:“缩短从症状发作到入院的时间可显著改善STEMI的预后。”

目的

确定影响STEMI患者死亡率的关键因素。

方法

我们研究了埃尔比勒心脏中心96例连续接受直接经皮冠状动脉介入治疗(PPCI)的STEMI患者。收集他们的临床病史,并在入院时进行冠状动脉造影评估。数据包括合并症、心源性休克的发作、PPCI期间的并发症等。出院后,完成了为期一个月的随访评估。设定统计学显著性为<0.05。

结果

我们的结果发现了几个重要发现。96例STEMI患者的住院死亡率和30天死亡率分别为11.2%和2.3%。在调查住院死亡率的独立预测因素时,我们确定了非典型表现、心源性休克的发作、慢性肾病的存在、心肌梗死溶栓分级0/1/2、三支血管病变、室性心动过速/心室颤动、冠状动脉夹层和无复流现象。具体而言,未存活患者从症状发作到入院的平均记录时间(6.92±3.86小时)明显长于存活患者(3.61±1.67小时),<0.001。这些发现强调了及时干预对改善STEMI患者生存结果的关键作用。

结论

我们的结果证实,症状发作后尽早入院可显著提高STEMI患者的生存率,突出了及时干预的迫切需求。

相似文献

本文引用的文献

1
Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma.
N Engl J Med. 2021 Apr 8;384(14):1289-1300. doi: 10.1056/NEJMoa2035716. Epub 2021 Feb 13.
2
Neuroinflammation: friend and foe for ischemic stroke.
J Neuroinflammation. 2019 Jul 10;16(1):142. doi: 10.1186/s12974-019-1516-2.
3
Collated data of mutation frequencies and associated genetic variants of bedaquiline, clofazimine and linezolid resistance in .
Data Brief. 2018 Sep 24;20:1975-1983. doi: 10.1016/j.dib.2018.09.057. eCollection 2018 Oct.
4
Culprit vessel: impact on short-term and long-term prognosis in patients with ST-elevation myocardial infarction.
Open Heart. 2018 Sep 5;5(2):e000852. doi: 10.1136/openhrt-2018-000852. eCollection 2018.
7
ECG diagnosis: ST-elevation myocardial infarction.
Perm J. 2014 Spring;18(2):e133. doi: 10.7812/TPP/13-127.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验